Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 6;82(7):1247–1248. doi: 10.1054/bjoc.1999.1085

A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer

I E Young 1, K M Kurian 1, M A F MacKenzie 1, I H Kunkler 2, B B Cohen 3, M L Hooper 1, A H Wyllie 1,4, C M Steel 3
PMCID: PMC2374487  PMID: 10755395

Abstract

The CYP19 gene codes for the aromatase enzyme that is involved in the synthesis of oestrogens. This case–control study examines the relationship between a tetranucleotide repeat sequence in the CYP19 gene and the development of male breast cancer. No significant differences were found between male breast cancer cases and controls. © 2000 Cancer Research Campaign

Keywords: CYP19, male breast cancer

Full Text

The Full Text of this article is available as a PDF (53.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. JACKSON A. W., MULDAL S., OCKEY C. H., O'CONNOR P. J. CARCINOMA OF MALE BREAST IN ASSOCIATION WITH THE KLINEFELTER SYNDROME. Br Med J. 1965 Jan 23;1(5429):223–225. doi: 10.1136/bmj.1.5429.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kristensen V. N., Andersen T. I., Lindblom A., Erikstein B., Magnus P., Børresen-Dale A. L. A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics. 1998 Feb;8(1):43–48. doi: 10.1097/00008571-199802000-00006. [DOI] [PubMed] [Google Scholar]
  3. Kurosaki K., Saitoh H., Oota H., Watanabe Y., Kiuchi M., Ueda S. Combined polymorphism associated with a 3-bp deletion in the 5'-flanking region of a tetrameric short tandem repeat at the CYP19 locus. Nihon Hoigaku Zasshi. 1997 Jun;51(3):191–195. [PubMed] [Google Scholar]
  4. Means G. D., Mahendroo M. S., Corbin C. J., Mathis J. M., Powell F. E., Mendelson C. R., Simpson E. R. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem. 1989 Nov 15;264(32):19385–19391. [PubMed] [Google Scholar]
  5. Polymeropoulos M. H., Xiao H., Rath D. S., Merril C. R. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res. 1991 Jan 11;19(1):195–195. doi: 10.1093/nar/19.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sasano H., Kimura M., Shizawa S., Kimura N., Nagura H. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. J Clin Endocrinol Metab. 1996 Aug;81(8):3063–3067. doi: 10.1210/jcem.81.8.8768875. [DOI] [PubMed] [Google Scholar]
  7. Siegelmann-Danieli N., Buetow K. H. Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. Br J Cancer. 1999 Feb;79(3-4):456–463. doi: 10.1038/sj.bjc.6690071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Young I. E., Kurian K. M., Annink C., Kunkler I. H., Anderson V. A., Cohen B. B., Hooper M. L., Wyllie A. H., Steel C. M. A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer. 1999 Sep;81(1):141–143. doi: 10.1038/sj.bjc.6690663. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES